Sylvester Comprehensive Cancer Center (@sylvestercancer) 's Twitter Profile
Sylvester Comprehensive Cancer Center

@sylvestercancer

South Florida’s only NCI-designated cancer center. Transforming discoveries from research labs to benefit our richly diverse patients and the entire community.

ID: 137901227

linkhttp://sylvester.org calendar_today28-04-2010 02:42:08

9,9K Tweet

8,8K Followers

1,1K Following

Sylvester Comprehensive Cancer Center (@sylvestercancer) 's Twitter Profile Photo

Dr. Carmen Calfa, MD joined Oncology Central to discuss her poster presentation at #ASCO25, which highlighted survival results for Bria-IMT + checkpoint inhibitors for metastatic breast cancer (MBC) patients. Read key takeaways from her #research, the impact of HLA matching on

Dr. <a href="/CarmenCalfa/">Carmen Calfa, MD</a> joined <a href="/OncologyCentral/">Oncology Central</a> to discuss her poster presentation at #ASCO25, which highlighted survival results for Bria-IMT + checkpoint inhibitors for metastatic breast cancer (MBC) patients. Read key takeaways from her #research, the impact of HLA matching on
Sylvester Comprehensive Cancer Center (@sylvestercancer) 's Twitter Profile Photo

Our Sylvester doctors and researchers attended the ASCO Annual Meeting to connect, collaborate and inspire. Watch this recap summarizing our participation at the leading global #oncology conference, helping to shape the future of cancer care. #ASCO25 #OnlySylvester 🔬

Sylvester Comprehensive Cancer Center (@sylvestercancer) 's Twitter Profile Photo

Dr. Frank Penedo studies the links between culture, behavior and chronic diseases, focusing on interventions that improve health outcomes. He also leads implementation research in South Florida communities with high cancer burdens. We recently chatted with Frank J Penedo, PhD to

Dr. Frank Penedo studies the links between culture, behavior and chronic diseases, focusing on interventions that improve health outcomes. He also leads implementation research in South Florida communities with high cancer burdens. We recently chatted with <a href="/DrFrankJPenedo/">Frank J Penedo, PhD</a> to
Oncology News Central (@oncnewscentral) 's Twitter Profile Photo

#ASCO25: ASMRs for #AlcoholRelated cancer deaths highest in men 55+: liver (38.5%), nasopharyngeal (31.8%). “Awareness of the alcohol-cancer link is low,” says Chinmay Jani of Sylvester Comprehensive Cancer Center. How are you bringing this up with patients? bit.ly/45zTloA #CancerPrevention

#ASCO25: ASMRs for #AlcoholRelated cancer deaths highest in men 55+: liver (38.5%), nasopharyngeal (31.8%). “Awareness of the alcohol-cancer link is low,” says <a href="/Jani_Chinmay/">Chinmay Jani</a> of <a href="/SylvesterCancer/">Sylvester Comprehensive Cancer Center</a>. How are you bringing this up with patients? bit.ly/45zTloA #CancerPrevention
Sylvester Comprehensive Cancer Center (@sylvestercancer) 's Twitter Profile Photo

Since 1952, volunteers from The Pap Corps Champions for Cancer Research have stood beside Sylvester, supporting innovative cancer research. During their annual president’s meeting breakfast The Pap Corps presented a ceremonial check for $3.4 million. To date, The Pap Corps has

Since 1952, volunteers from The <a href="/Pap_Corps/">Pap Corps</a> Champions for Cancer Research have stood beside Sylvester, supporting innovative cancer research.

During their annual president’s meeting breakfast The Pap Corps presented a ceremonial check for $3.4 million. To date, The Pap Corps has
UroToday.com (@urotoday) 's Twitter Profile Photo

The use of radioligand treatments in metastatic castration-resistant #ProstateCancer. Matthew Abramowitz, MD Sylvester Comprehensive Cancer Center joins Rana McKay, MD, FASCO UC San Diego to discuss as part of this Independent Medical Education Initiative on UroToday > bit.ly/4cZktif Bayer | Pharmaceuticals

The use of radioligand treatments in metastatic castration-resistant #ProstateCancer. Matthew Abramowitz, MD <a href="/SylvesterCancer/">Sylvester Comprehensive Cancer Center</a> joins <a href="/DrRanaMcKay/">Rana McKay, MD, FASCO</a> <a href="/UCSanDiego/">UC San Diego</a> to discuss as part of this Independent Medical Education Initiative on UroToday &gt; bit.ly/4cZktif <a href="/BayerPharma/">Bayer | Pharmaceuticals</a>
Sylvester Comprehensive Cancer Center (@sylvestercancer) 's Twitter Profile Photo

We work closely with our patients to understand their diagnosis, treatment plans and #nutrition and #diet needs and goals. CRANE Lab joins us to discuss the importance of portion sizes and how to build a healthy plate. To tune in to our full nutrition series, visit:

Sylvester Comprehensive Cancer Center (@sylvestercancer) 's Twitter Profile Photo

Doctors and #researchers at Sylvester are making significant strides in the treatment of #melanoma, the deadliest form of skin #cancer—especially as cases continue to rise. Learn how Dr. Barbara Bedogni’s team is advancing lab discoveries, while Dr. Jose Lutzky (Jose Lutzky, MD, FACP)

Doctors and #researchers at Sylvester are making significant strides in the treatment of #melanoma, the deadliest form of skin #cancer—especially as cases continue to rise.

Learn how Dr. Barbara Bedogni’s team is advancing lab discoveries, while Dr. Jose Lutzky (<a href="/LutzkyJose/">Jose Lutzky, MD, FACP</a>)
UroToday.com (@urotoday) 's Twitter Profile Photo

#PORTOS biomarker guides radiation dose escalation in #ProstateCancer treatment. George Zhao, MD UW School of Medicine and Public Health & Alan Dal Pra, MD Sylvester Comprehensive Cancer Center join Alicia Morgans, MD, MPH Dana-Farber to discuss updates to the PORTOS trial and how it predicts radiation benefit in #PCa. #WatchNow >

#PORTOS biomarker guides radiation dose escalation in #ProstateCancer treatment. George Zhao, MD <a href="/uwsmph/">UW School of Medicine and Public Health</a> &amp; <a href="/a_dalpra/">Alan Dal Pra, MD</a> <a href="/SylvesterCancer/">Sylvester Comprehensive Cancer Center</a> join <a href="/CaPsurvivorship/">Alicia Morgans, MD, MPH</a> <a href="/DanaFarber/">Dana-Farber</a> to discuss updates to the PORTOS trial and how it predicts radiation benefit in #PCa. #WatchNow &gt;
Sylvester Comprehensive Cancer Center (@sylvestercancer) 's Twitter Profile Photo

🚨 New Grant to Transform Prostate Cancer Care: Hormone and radiation #therapy is standard for high-risk #prostate cancer, but it brings harsh side effects & limited personalization. Backed by a $2.6M National Cancer Institute grant, Sylvester #researchers are using MRI & liquid biopsy to build a

🚨 New Grant to Transform Prostate Cancer Care: Hormone and radiation #therapy is standard for high-risk #prostate cancer, but it brings harsh side effects &amp; limited personalization.

Backed by a $2.6M <a href="/theNCI/">National Cancer Institute</a> grant, Sylvester #researchers are using MRI &amp; liquid biopsy to build a
Sylvester Comprehensive Cancer Center (@sylvestercancer) 's Twitter Profile Photo

Once #radiology identifies the target, #radiation #oncology takes aim. Together, these specialties form a seamless, patient-centered approach. “We’ve moved from uncertainty to precision,” says Dr. Markus Bredel (Markus Bredel M.D. Ph.D.), chair of radiation oncology at Sylvester. “We

Once #radiology identifies the target, #radiation #oncology takes aim. Together, these specialties form a seamless, patient-centered approach. 

“We’ve moved from uncertainty to precision,” says Dr. Markus Bredel (<a href="/drbredel/">Markus Bredel M.D. Ph.D.</a>), chair of radiation oncology at Sylvester. “We
SurvivorNet (@survivornetteam) 's Twitter Profile Photo

When you’re facing prostate cancer, no single scan tells the whole story. Doctors use PSMA PET, CT, MRI scans and more to track spread, guide treatment, and stay ahead. Dr. Janaki Sharma of Sylvester Comprehensive Cancer Center shares why monitoring matters. #pcsm

Doctor Radio (@nyudocs) 's Twitter Profile Photo

Alcohol-related cancers are on the rise, especially in men over age 55. Tune in at 2:30pm East as Marc Siegel MD talks about a new study with Dr. Gilberto Lopes gilberto lopes, Chief of Medical Oncology at Sylvester Comprehensive Cancer Center @UnivMiami. Listen here: sxm.app.link/DoctorRadio

Sylvester Comprehensive Cancer Center (@sylvestercancer) 's Twitter Profile Photo

Sylvester researcher and resident physician Dr. Ifeanyichukwu Ogobuiro (Ifeanyichukwu Ogobuiro, MD, MHS) has been awarded a prestigious 2025 Research Resident Grant from RSNA to support his cutting-edge research on radiation resistance in glioblastoma (#GBM). Learn what his research will

Sylvester researcher and resident physician Dr. Ifeanyichukwu Ogobuiro (<a href="/IOgobuiro/">Ifeanyichukwu Ogobuiro, MD, MHS</a>) has been awarded a prestigious 2025 Research Resident Grant from <a href="/RSNA/">RSNA</a> to support his cutting-edge research on radiation resistance in glioblastoma (#GBM).

Learn what his research will
Sylvester Comprehensive Cancer Center (@sylvestercancer) 's Twitter Profile Photo

.American Cancer Society (ACS) is fueling the next wave of cancer breakthroughs through #research grants awarded to four early-career Sylvester investigators. 2025 Sylvester ACS-IRG Awardees: • Nicholas A. Borja, M.D. • Mariana Cooke, M.D., Ph.D. • Noa Geifman Holtzman, M.D. •

.<a href="/AmericanCancer/">American Cancer Society</a> (ACS) is fueling the next wave of cancer breakthroughs through #research grants awarded to four early-career Sylvester investigators.

2025 Sylvester ACS-IRG Awardees:
• Nicholas A. Borja, M.D.
• Mariana Cooke, M.D., Ph.D.
• Noa Geifman Holtzman, M.D.
•
Wafik S. El-Deiry, MD, PhD, FACP (@weldeiry) 's Twitter Profile Photo

Pleased to share collaborative manuscript by Totiger et al. with Caris Life Sciences and Dr. Justin Taylor at Sylvester Comprehensive Cancer Center (Nuclear Export Receptor) XPO1R749Q Mutations Co-occur with POLE Mutations in Cancer and can be Targeted to Overcome Chemoresistance pubmed.ncbi.nlm.nih.gov/40531821/